Translation of health technology reassessment and its outputs of disinvestment, de-implementation and de-adoption of drugs and medical devices in practice-what have we learned?

3,083
Total downloads
15k
Total views and downloads

Articles

EDITORIAL

Published on 13 Oct 2025

Editorial: Translation of health technology reassessment and its outputs of disinvestment, de-implementation and de-adoption of drugs and medical devices in practice-what have we learned?

Rosmin Esmail
Nora Ibargoyen-Roteta
Maximilian Otte
Iñaki Gutiérrez-Ibarluzea
Roberta Joppi
Hans-Peter Dauben

doi 10.3389/fphar.2025.1700196

492 views

ORIGINAL RESEARCH

Published on 10 Jan 2025

Survival analysis of a 16-year cohort of follicular lymphoma patients receiving systemic treatment in Brazil

Pamela Santos Azevedo
Isabella Zuppo Laper
Deborah Marta do Santos Oliveira
Adriano de Paula Sabino
Marina Morgado Garcia
Isabela Cristina Menezes de Freitas
Wallace Mateus Prata
Mariângela Leal Cherchiglia
Juliana Álvares-Teodoro
1 more
Augusto Afonso Guerra Júnior

doi 10.3389/fphar.2024.1414244

1,563 views
1 citation

ORIGINAL RESEARCH

Published on 03 Dec 2024

Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China

Xiang Xiao
Shuming Ji
Tao Zheng
Tianzhu Wang
Dapeng Jiang
Fang Liu

doi 10.3389/fphar.2024.1468435

1,769 views
1 citation

ORIGINAL RESEARCH

Published on 26 Sep 2024

Gaucher disease in Brazil: a comprehensive 16 year retrospective study on survival, cost, and treatment insights

Marcus Carvalho Borin
Juliana Alvares-Teodoro
Francisco Assis Acurcio
Augusto Afonso Guerra

doi 10.3389/fphar.2024.1433970

2,021 views
2 citations

DATA REPORT

Published on 06 Aug 2024

History of trastuzumab: a case study in health technology reassessment and natural disinvestment in Veneto Region

Antonella Giorgia Becchetti
Anna Martini
Giovanna Scroccaro
Roberta Joppi

doi 10.3389/fphar.2024.1406351

2,362 views

ORIGINAL RESEARCH

Published on 11 Jan 2024

Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745

Cristina Andrés-Iglesias
Ivan Fernandez-Bueno
Salvador Pastor-Idoate
Rosa M. Coco-Martin
J. Carlos Pastor

doi 10.3389/fphar.2023.1310463

3,369 views
1 citation

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Drugs Outcomes Research and Policies

Impact

15kTopic views
10kArticle views
3,083Article downloads